Solid cancers

Early clinical results suggest that FT836, an off-the-shelf CAR T-cell therapy derived from induced pluripotent stem cells (iPSCs), may induce tumour...

Solid cancers

Non-small Cell Lung Cancer, NSCLC, (NCT06097962)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Gastric Cancer and Colorectal Cancer, CRC, (NCT07166263)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Soft Tissue Sarcoma, (NCT06117878)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Gastric Cancer, (NCT06098898)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Ovarian Cancer, OC, (NCT06846424)
Sponsors:
Shanghai Gynecologic Oncology Group

IND Enabling

Phase I

Phase II

Phase III

High-grade Squamous Intraepithelial Lesions, HSIL, (NCT07170254)
Sponsors:
Shanghai BDgene Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Ovarian Cancer, OC, (NCT07067255)
Sponsors:
Essen Biotech

IND Enabling

Phase I

Phase II

Phase III

Advanced Primary or Secondary Peritoneal Tumors, (NCT07004647)
Sponsors:
Ruijin Hospital

IND Enabling

Phase I

Phase II

Phase III